Posts

Showing posts with the label rheumatoid arthritis testing

Global Autoimmune Disease Diagnostics Market to Surpass US$10 Billion by 2032 Rising Driven by Disease Burden and Personalized Testing

Image
Industry Experts, Inc. has introduced its latest market research report, " Autoimmune Disease Diagnostics - A Global Market Overview ," estimating that worldwide revenues will rise from US$6.2 billion in 2025 to US$10.2 billion by 2032 , growing at a CAGR of 7.5% during 2025 to 2032. Market expansion is driven by the rising global prevalence of more than 100 autoimmune disorders, including rheumatoid arthritis, lupus, multiple sclerosis, and type 1 diabetes, coupled with heightened awareness, early testing initiatives, and technological advancements in immunoassays, biomarkers, and molecular diagnostics. Advances in genomics, proteomics, bioinformatics, and AI-driven automation are significantly improving sensitivity, specificity, and turnaround time across diagnostic platforms. Growing adoption of multiplex and next-generation sequencing assays, together with machine-learning–based interpretation tools, is enabling precision diagnostics and personalized m...

Global ANA Testing Market to Reach US$4.9 Billion by 2032 Driven by Growing Autoimmune Burden and AI-Powered Diagnostics

Image
Industry Experts, Inc. has unveiled a new market research report, " Anti-Nuclear Antibody (ANA) Testing - A Global Market Overview ," estimating that global revenues from ANA testing are projected to climb from US$2.1 billion in 2025 to surpass US$4.9 billion by 2032, advancing at a CAGR of 12.5% during the analysis period. The growth of the ANA testing market is being powered by rising autoimmune disease prevalence worldwide, including lupus, rheumatoid arthritis, scleroderma, and Sjogren's syndrome. Increased awareness and early screening initiatives, together with favorable reimbursement policies and government-supported diagnostic programs, are fueling test volumes. Technological innovations, such as multiplex immunoassays, automation, and AI-based interpretation, are reshaping the diagnostic landscape by improving accuracy, scalability, and clinical confidence. Furthermore, expanding applications in biomarker-based research, personalized medicine, and p...